Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Over 68 weeks, the 12 mg dose led to a 28.7% body-weight loss, the 9 mg dose to 26.4%, and the placebo to 2.1%
It is not intended for human or veterinary application
The index is forecast to be down 0.3% for the month, after a big 6.6% decline in June
Retatrutide may be of interest to individuals who: Did not tolerate GLP-1 alone Are exploring metabolic flexibility Are interested in appetite and energy expenditure pathways However, retatrutide remains under clinical investigation and is not broadly FDA-approved for obesity at the time of writing
US$ 29.19
US$ 21.03
US$ 29.55
US$ 24.67
US$ 29.14
US$ 23.99
US$ 21.51
US$ 25.42
